madopar hbs capsule (100/25)
roche products pty ltd - benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg); levodopa, quantity: 100 mg - capsule, hard - excipient ingredients: mannitol; indigo carmine; iron oxide yellow; hypromellose; titanium dioxide; magnesium stearate; purified talc; gelatin; hydrogenated vegetable oil; povidone; calcium hydrogen phosphate dihydrate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; iron oxide red; ethanol absolute; potassium hydroxide; ammonia - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism. madopar hbs is indicated for patients presenting with all types of fluctuations in response (i.e. "peak dose dyskinesia" and "end of dose deterioration") and for better control of nocturnal symptoms.
prolopa 250 200 mg - 50 mg comp.
roche sa-nv - lévodopa 200 mg; chlorhydrate de bensérazide 57 mg - eq. bensérazide 50 mg - comprimé - 200 mg - 50 mg - lévodopa 200 mg; chlorhydrate de bensérazide 57 mg - levodopa and decarboxylase inhibitor
madopar tablets dispersible 100mg/25mg
cherubino limited delf building, sliema road, gzira, gzr 1637, malta - benserazide, levodopa - dispersible tablet - benserazide 25 mg levodopa 100 mg - anti-parkinson drugs
madopar rapid 62.5 dispersible 62.5mg tablet bottle
roche products pty ltd - benserazide hydrochloride, quantity: 14.25 mg (equivalent: benserazide, qty 12.5 mg); levodopa, quantity: 50 mg - tablet, dispersible - excipient ingredients: magnesium stearate; pregelatinised maize starch; citric acid; microcrystalline cellulose - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.
madopar
boehringer ingelheim indonesia - indonesia - benserazide hydrochloride, levodopa - tablet dispersible - 28.5 mg /100 mg
madopar
boehringer ingelheim indonesia - indonesia - benserazide hydrochloride; levodopa - tablet dispersible - 100/25 mg
levodopa/benserazide orifarm 100 mg/25 mg tablett
orifarm healthcare a/s - benserazidhydroklorid; levodopa - tablett - 100 mg/25 mg - benserazidhydroklorid 28,54 mg aktiv substans; mannitol hjälpämne; levodopa 100 mg aktiv substans
madopar
roche products (nz) ltd - benserazide hydrochloride 50mg; ; levodopa 200mg; - tablet - 250 mg - active: benserazide hydrochloride 50mg levodopa 200mg
madopar dispersible
roche products (nz) ltd - benserazide hydrochloride 25mg; ; ; levodopa 100mg; - dispersible tablet - 125 mg - active: benserazide hydrochloride 25mg levodopa 100mg excipient: citric acid magnesium stearate maize starch microcrystalline cellulose
prolopa cap 100-25 capsule
hoffmann-la roche limited - levodopa; benserazide (benserazide hydrochloride) - capsule - 100mg; 25mg - levodopa 100mg; benserazide (benserazide hydrochloride) 25mg - dopamine precursors